1. Home
  2. IDT vs GPCR Comparison

IDT vs GPCR Comparison

Compare IDT & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDT Corporation Class B

IDT

IDT Corporation Class B

HOLD

Current Price

$51.40

Market Cap

1.2B

ML Signal

HOLD

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$65.71

Market Cap

1.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDT
GPCR
Founded
1990
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Sector
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
1996
2023

Fundamental Metrics

Financial Performance
Metric
IDT
GPCR
Price
$51.40
$65.71
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
$94.90
AVG Volume (30 Days)
168.5K
2.6M
Earning Date
12-04-2025
11-06-2025
Dividend Yield
0.46%
N/A
EPS Growth
10.35
N/A
EPS
3.22
N/A
Revenue
$1,244,681,000.00
N/A
Revenue This Year
$0.77
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$16.19
N/A
Revenue Growth
2.52
N/A
52 Week Low
$44.77
$13.22
52 Week High
$71.12
$94.90

Technical Indicators

Market Signals
Indicator
IDT
GPCR
Relative Strength Index (RSI) 51.95 76.12
Support Level $47.30 $65.02
Resistance Level $52.72 $72.39
Average True Range (ATR) 1.80 6.51
MACD 0.30 3.23
Stochastic Oscillator 52.02 55.13

Price Performance

Historical Comparison
IDT
GPCR

About IDT IDT Corporation Class B

IDT Corp is a multinational holding company. It operates in the telecommunications and payment industries. It has four reportable business segments, Fintech, National Retail Solutions; net2phone and Traditional Communications, The Fintech segment is comprised of National Retail Solutions (NRS), an operator of a nationwide point of sale (POS) network providing payment processing, digital advertising, transaction data, and ancillary services, and BOSS Money, a provider of international money remittance and related value/payment transfer services. The net2phone segment provides unified cloud communications and telephony services to business customers.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: